DoW Kidney Cancer, Idea Development Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 18, 2026
- Amount
- Program total $7.8M
- Closes
- Sep 28, 2026 (in 12 days)
Similar opportunities open now
- DoW Rare Cancers Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 63 days
- DoW Rare Cancers Concept AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 14 days
- DoW Kidney Cancer, Academy of Kidney Cancer Investigators – Early-Career Scholar AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 12 days
- DoW Parkinson’s, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 51 days
- DoW Duchenne Muscular Dystrophy, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 2 days
Classification and identifiers
- Solicitation number
- HT942526KCRPIDA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $7.8M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Kidney Cancer Research Program (KCRP) Idea Development Award (IDA) supports the development of high-impact ideas that advance the understanding of kidney cancer and ultimately lead to improved patient outcomes. The research project should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach. Personnel on the proposed team should have a strong background in kidney cancer research. Distinctive Features: · Partnering Principal Investigator Option: Supports meaningful and productive partnerships between two investigators, termed the Initiating Principal Investigator (PI) and Partnering PI, collaborating on a single application. Only the Initiating PI will submit a pre-appl...